| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
22.450 |
Evidence |
|
| SSB |
SSB: Lupus La protein |
DDX5 |
DDX5, G17P1, HELR, HLR1: Probable ATP-dependent RNA helicase DDX5 |
22.450 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
22.450 |
Evidence |
|
| UTX |
UTX: Ubiquitously transcribed X chromosome tetratricopeptide repeat protein |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
22.450 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
22.450 |
Evidence |
|
| PRKAB2 |
PRKAB2: 5'-AMP-activated protein kinase subunit beta-2 |
PRKAG2 |
PRKAG2: 5'-AMP-activated protein kinase subunit gamma-2 |
22.430 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
IRS2 |
IRS2: Insulin receptor substrate 2 |
22.430 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
22.430 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
22.430 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
22.430 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
22.430 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
22.430 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
22.430 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
22.430 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
22.430 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
PLEKHA5 |
PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member |
22.430 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
22.430 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
22.430 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
22.430 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
22.430 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
22.430 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
22.430 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
22.430 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
22.430 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
22.430 |
Evidence |
|
- 
-